The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
The Race to Commercialize the World’s Most Powerful Psychedelic | WSJ
Posted
July 14, 2026
Views
328,027
Likes
7,809
Comments
1,131
Engagement
July 14, 2026
328,027
7,809
1,131
2.73%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
15:10Now PlayingAn obscure and extremely powerful psychedelic drug called 5-MeO-DMT, or BUFO, is drawing intense interest from the pharmaceutical industry, where biotech companies like AtaiBeckley and GH Research are racing to turn it into a commercially available treatment for severe mental health disorders, like depression, anxiety and PTSD.
WSJ took an inside look at how the psychedelic is being used at unregulated clinics in Mexico, and why companies are betting that it could soon turn into a billion dollar blockbuster drug.
Chapters:
WSJ Originals features in-depth reporting, investigations and on-the-ground journalism that uncovers the forces shaping business, politics and the world around us.
#DMT #Psychedlics #WSJ
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
